gene therapy
Purespring Therapeutics Raises £80M in Series B Round to Launch Kidney Disease Gene Therapy Trial
The London-based firm said it will use the funds to advance its gene therapy pipeline, including its lead program in IgA nephropathy.
Intellia Starts Phase III Hereditary Angioedema Trial for CRISPR Gene-Editing Therapy
In the HAELO trial, the firm will randomize 60 HAE patients to NTLA-2002 or placebo and compare the number of inflammatory attacks.
Astellas Strikes Exclusive Option Deal for AviadoBio's Frontotemporal Dementia Gene Therapy
Astellas will make a $20 million equity investment in AviadoBio for the option to exclusively develop and commercialize AVB-101.
Editas Medicine Raises $57M by Selling Future Payments From CRISPR Licensing Deal With Vertex Pharma
Editas will receive $57 million in upfront cash from DRI Healthcare Trust in exchange for certain future licensing fees and payments it is owed under an earlier deal with Vertex.
In Brief This Week: Modalis, Otsuka, CSL Behring, Papillon, Anixa Biosciences, PathAI
News items for the week of Sept. 30, 2024.
Sep 17, 2024